|
Tissue
|
|
3wCon/Sed
|
3wTau/Sed
|
3wCon/Exe
|
3wTau/Exe
|
|
GC-W
|
(nmol·mg-1)
|
13.8 (.3)
|
21.0 (.3) ‡
|
14.1 (.3)
|
20.1 (.3) ‡*
|
|
GC-R
|
(nmol·mg-1)
|
21.4 (.7)
|
29.0 (.7) ‡
|
21.7 (.7)
|
27.8 (.7) ‡
|
|
Plantaris
|
(nmol·mg-1)
|
18.3 (.6)
|
24.0 (.6) ‡
|
17.8 (0.6)
|
23.3 (.6) ‡
|
|
Liver
|
(nmol·mg-1)
|
2.1 (1.8)
|
17.9 (1.8) ‡
|
5.0 (2.0)
|
13.2 (1.8) ‡
|
|
Plasma
|
(nmol·mg-1)
|
326 (288)
|
876 (561) ‡
|
481 (396)
|
1201 (430) ‡
|
Footnote: ‡, p < 0.01 for the significant
difference to the respective non-supplemented control group by two-way
ANOVA. *, p < 0.05 for the significant difference to the 3wTau/Sed
group by two-way ANOVA followed by Bonferroni’s post hoc analysis. Abbreviations:
3wCon/Sed; three-week non-supplemented and sedentary group, 3wTau/Sed;
three-week taurine-supplemented and sedentary group, 3wCon/Exe; three-week
non-supplemented and exercised group, 3wCon/Exe; three-week taurine-supplemented
and exercised group, and see the footnote of Table 1 for other abbreviations.
|